MEDP
USDMedpace Holdings Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$301.620
Kõrge
$301.910
Madal
$301.170
Maht
0.31M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
8.7B
Tööstusharu
Diagnostics & Research
Riik
United States
Kauplemisstatistika
Keskmine maht
0.49M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Truist Securities Maintains Hold on Medpace Hldgs, Lowers Price Target to $300
Truist Securities analyst Jailendra Singh maintains Medpace Hldgs with a Hold and lowers the price target from $333 to $300.
Baird Maintains Neutral on Medpace Hldgs, Lowers Price Target to $313
Baird analyst Eric Coldwell maintains Medpace Hldgs with a Neutral and lowers the price target from $340 to $313.
William Blair Downgrades Medpace Hldgs to Market Perform
William Blair analyst Max Smock downgrades Medpace Hldgs from Outperform to Market Perform.
Medpace Holdings, Inc. Reports First Quarter 2025 Results
Revenue of $558.6 million in the first quarter of 2025 increased 9.3% from revenue of $511.0 million for the comparable prior-year period, representing a backlog conversion rate of 19.2%. Net new business awards were
TD Cowen Downgrades Medpace Hldgs to Hold, Lowers Price Target to $328
TD Cowen analyst Charles Rhyee downgrades Medpace Hldgs from Buy to Hold and lowers the price target from $370 to $328.
Truist Securities Maintains Hold on Medpace Hldgs, Lowers Price Target to $333
Truist Securities analyst Jailendra Singh maintains Medpace Hldgs with a Hold and lowers the price target from $347 to $333.
Mizuho Maintains Outperform on Medpace Hldgs, Lowers Price Target to $355
Mizuho analyst Ann Hynes maintains Medpace Hldgs with a Outperform and lowers the price target from $400 to $355.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.